Qianwei Zhao
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Plasma anti-DLAT autoantibody as a novel diagnostic biomarker in breast cancer.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 28, 2025
Hepatocellular carcinoma cells downregulate PGAM2 via SIRT2-mediated deacetylation modification to enhance aerobic glycolysis.
Journal: NPJ precision oncology
Published: November 07, 2024
GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: June 27, 2024
Structural Insight into Polymerase Mechanism via a Chiral Center Generated with a Single Selenium Atom.
Journal: International journal of molecular sciences
Published: September 21, 2023
Hepatocellular carcinoma cells downregulate NADH:Ubiquinone Oxidoreductase Subunit B3 to maintain reactive oxygen species homeostasis.
Journal: Hepatology communications
Published: August 09, 2023
GLUD1 inhibits hepatocellular carcinoma progression via ROS-mediated p38/JNK MAPK pathway activation and mitochondrial apoptosis.
Journal: Discover oncology
Published: July 20, 2023
BCAT1 promotes lung adenocarcinoma progression through enhanced mitochondrial function and NF-κB pathway activation.
Journal: Journal of Zhejiang University. Science. B
Published: September 16, 2022
Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC.
Journal: Oncogene
Published: March 26, 2021
BCAT1 knockdown-mediated suppression of melanoma cell proliferation and migration is associated with reduced oxidative phosphorylation.
Journal: American journal of cancer research
Published: January 09, 2021
Last Updated: 09/26/2026